6-K 1 a3600t.htm DIRECTOR/PDMR SHAREHOLDING a3600t
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of July 2022
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
England and Wales
(Jurisdiction of Incorporation)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
 
 
 
 
 
 
 
EXHIBIT INDEX
 
Exhibit
Number
 
Description
99.1
 
Press Release entitled Director/PDMR Shareholding dated July 21, 2022
 
 
 
 
99.1
 
HALEON PLC 
 
 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 
 
21 July 2022 
 
Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them. 
 
On 21 July 2022, Haleon plc (the "Company") received notification of the following transactions as detailed below. 
 
1  
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Tobias Hestler 
2  
 
Reason for the notification  
 
a)  
 
Position/status  
 
 
Chief Financial Officer - Person Discharging Managerial Responsibilities 
b)  
 
Initial notification /Amendment  
 
Initial Notification 
3  
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
4  
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of the financial instrument, type of instrument  
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 
 
 
Identification code  
GB00BMX86B70   
 
 
b)  
 
Nature of the transaction  
 
 
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
 
 
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
n/a 
1,033 
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
1,033 
 
 
- Price 
n/a 
 
 
e)  
 
Date of the transaction  
 
18 July 2022 
f)  
 
Place of the transaction  
 
London Stock Exchange 
 
 
 
1  
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
 
Amy Landucci 
2  
 
Reason for the notification  
 
a)  
 
Position/status  
 
 
Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities 
b)  
 
Initial notification /Amendment  
 
 
Initial Notification 
3  
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
 
Haleon plc 
b)  
 
LEI  
 
 
549300PSB3WWEODCUP19 
4  
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of the financial instrument, type of instrument  
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 
 
 
Identification code  
GB00BMX86B70   
 
 
b)  
 
Nature of the transaction  
 
 
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.  
 
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
n/a 
379
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
379 
 
 
- Price 
n/a 
 
 
e)  
 
Date of the transaction  
 
 
18 July 2022 
f)  
 
Place of the transaction  
 
 
London Stock Exchange 
 
 
1  
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Bart Derde 
2  
 
Reason for the notification  
 
a)  
 
Position/status  
 
 
Chief Supply Chain Officer - Person Discharging Managerial Responsibilities 
b)  
 
Initial notification /Amendment  
 
Initial Notification 
3  
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
4  
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
 
a)  
 
Description of the financial instrument, type of instrument  
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). 
 
 
Identification code  
GB00BMX86B70   
 
 
b)  
 
Nature of the transaction  
 
 
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
 
 
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
n/a 
837
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
837 
 
 
- Price 
n/a 
 
 
e)  
 
Date of the transaction  
 
18 July 2022 
f)  
 
Place of the transaction  
 
London Stock Exchange 
 
 
1  
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
 
Jooyong Lee 
2  
 
Reason for the notification  
 
a)  
 
Position/status  
 
 
Head of Strategy and Office of the CEO - Person Discharging Managerial Responsibilities 
b)  
 
Initial notification /Amendment  
 
Initial Notification 
3  
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
4  
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of the financial instrument, type of instrument  
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 
 
 
Identification code  
GB00BMX86B70   
 
 
b)  
 
Nature of the transaction  
 
 
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
 
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
n/a 
386 
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
386 
 
 
- Price 
n/a 
 
 
e)  
 
Date of the transaction  
 
 
18 July 2022 
f)  
 
Place of the transaction  
 
London Stock Exchange 
 
 
1  
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Tamara Rogers 
2  
 
Reason for the notification  
 
a)  
 
Position/status  
 
 
Chief Marketing Officer - Person Discharging Managerial Responsibilities 
b)  
 
Initial notification /Amendment  
 
Initial Notification 
3  
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
 
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
4  
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 
a)  
 
Description of the financial instrument, type of instrument  
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). 
 
 
Identification code  
GB00BMX86B70   
 
 
b)  
 
Nature of the transaction  
 
 
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
 
c)  
 
Price(s) and volume(s)  
 
 
 
 
 
 
Price(s) 
Volume(s) 
 
 
 
n/a 
937 
 
 
 
 
 
 
d)  
 
Aggregated information  
 
 
 
- Aggregated volume 
937 
 
 
- Price 
n/a 
 
 
e)  
 
Date of the transaction  
 
18 July 2022 
f)  
 
Place of the transaction  
 
London Stock Exchange 
 
 
Amanda Mellor 
Company Secretary 
 
 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
HALEON PLC
(Registrant)
 
Dated: July 21, 2022
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary